Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VIveve Treatment of the Vaginal Introitus to EValuate Effectiveness

NCT02261974 is registered in ClinicalTrials.gov with Viveve Inc. as lead sponsor.

NCT NCT02261974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02261974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VIveve Treatment of the Vaginal Introitus to EValuate Effectiveness
Lead sponsor
Viveve Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
April 30, 2016
Enrollment
186 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

sexual function following childbirth, vaginal laxity following childbirth